HELEN NGUYEN: Open Payments
NPI 1346864139 · PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,350 in 53 payments from 16 companies in 2025. Trend: 2023 $1,522 · 2024 $2,054 · 2025 $1,350
Food & beverage: $1,350
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $197 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $196 |
| ABBVIE INC. | 12 | $181 |
| Gilead Sciences, Inc. | 7 | $155 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $136 |
| Braintree Laboratories, Inc. | 5 | $113 |
| Ipsen Biopharmaceuticals, Inc | 1 | $103 |
| Ardelyx, Inc. | 2 | $52 |
| QOL Medical, LLC | 1 | $44 |
| Medtronic, Inc. | 1 | $34 |
Products named: TREMFYA, XIFAXAN, ENTYVIO, IQIRVO, LINZESS, SUFLAVE, EOHILIA, IBSRELA.
Industry payments across RI — which companies pay providers there.
